Events Details
RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc
Thursday, October 13, 2016
RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc. RXi Pharmaceuticals Corp - can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April 5, 2017.
RXi Pharmaceuticals Corp - deal for number of shares equal to 19.99% of then outstanding shares of common stock of RXi.
RXi Pharmaceuticals Corp - entered into an option agreement to acquire all outstanding capital stock of Mirimmune Inc. RXi Pharmaceuticals Corp - deal also provides for additional potential consideration contingent on Mirimmune reaching certain milestones.
Source : reuters.com
